Aratana Therapeutics Inc (Aratana) is a pet therapeutics company that licenses, develops and markets biopharmaceutical products for medical condition in cats and dogs. The company's pipeline portfolio consists of small molecule pharmaceuticals and large molecule biologics that aim for the treatment serious conditions in pets. The lead products candidates include GALLIPRANT (AT-001), for the treatment of osteoarthritis pain and inflammation; ENTYCE (AT-002), for appetite stimulation and NOCITA (AT-003), for post-operative pain in dogs. It offers products for the therapeutic areas of osteoarthritis pain, post-operative pain, inappetence, cancer, viral diseases, allergy and among others. The company has its presence in Leuven, Belgium; Boston, Massachusetts and San Deigo, California in the US. Aratana is headquartered in Leawood, Kansas, the US.
Aratana Therapeutics Inc Key Recent Developments
Nov 03, 2016: Aratana Therapeutics Reports Third Quarter 2016 Financial Results
This comprehensive SWOT profile of Aratana Therapeutics Inc provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Aratana Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
Business description-A detailed description of the company's operations and business divisions.
Corporate strategy-Analyst's summarization of the company's business strategy.
SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history-Progression of key events associated with the company.
Major products and services-A list of major products, services and brands of the company.
Key competitors-A list of key competitors to the company.
Key employees-A list of the key executives of the company.
Executive biographies-A brief summary of the executives' employment history.
Key operational heads-A list of personnel heading key departments/functions.
Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities-A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1-About the Company
Aratana Therapeutics Inc-Key Information
Aratana Therapeutics Inc-Overview
Aratana Therapeutics Inc-Key Employees
Aratana Therapeutics Inc-Key Employee Biographies
Aratana Therapeutics Inc-Key Operational Heads
Aratana Therapeutics Inc-Major Products and Services
Aratana Therapeutics Inc-History
Aratana Therapeutics Inc-Company Statement
Aratana Therapeutics Inc-Locations And Subsidiaries
Aratana Therapeutics Inc-Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2-Company Analysis
Aratana Therapeutics Inc-Business Description
Aratana Therapeutics Inc-Corporate Strategy
Aratana Therapeutics Inc-SWOT Analysis
Aratana Therapeutics Inc-Strengths
Aratana Therapeutics Inc-Weaknesses
Aratana Therapeutics Inc-Opportunities
Aratana Therapeutics Inc-Threats
Aratana Therapeutics Inc-Key Competitors
Section 3-Company Financial Performance Charts
Aratana Therapeutics Inc-Financial Ratios
Financial Ratios-Capital Market Ratios
Financial Ratios-Annual Ratios
Financial Ratios-Interim Ratios
Financial Ratios-Ratio Charts
Note*: Some sections may be missing if data is unavailable for the company
List of Figures
Aratana Therapeutics Inc, Performance Chart
Aratana Therapeutics Inc, Ratio Charts
List of Tables
Aratana Therapeutics Inc, Key Information
Aratana Therapeutics Inc, Key Ratios
Aratana Therapeutics Inc, Share Data
Aratana Therapeutics Inc, Major Products and Services
Aratana Therapeutics Inc, History
Aratana Therapeutics Inc, Key Employees
Aratana Therapeutics Inc, Key Employee Biographies
Aratana Therapeutics Inc, Key Operational Heads
Aratana Therapeutics Inc, Other Locations
Aratana Therapeutics Inc, Subsidiaries
Aratana Therapeutics Inc, Key Manufacturing facilities
Aratana Therapeutics Inc, Key Competitors
Aratana Therapeutics Inc, SWOT Analysis
Aratana Therapeutics Inc, Ratios based on current share price
Aratana Therapeutics Inc, Annual Ratios
Aratana Therapeutics Inc, Interim Ratios
Capital Market Ratios
Single User License:
Corporate User License:
select a license
NEWSLETTER BY CATEGORY
The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"
This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"
I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"
While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"
We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"